MARKETSBiocon Launches Yesafili in US, Stock Touches Day High of Rs 429Tabassum ChaudharyAugust 3, 2026August 3, 2026 August 3, 2026August 3, 2026 Biocon surges to Rs 429 on Monday after the company launched its Eylea biosimilar Yesafili in the United States ophthalmology market. Yesafili is Biocon’s biosimilar...